These nanoplatforms can achieve tumor-specific and controllable STING activation, thereby minimizing off-target toxicity, and can be combined with chemotherapy, radiotherapy, or photodynamic therapy to produce multimodal synergistic antitumor effects. The gene discussed is STING1; the disease is neoplasm.